The ability to express heterologous antigens from attenuated poliovirus strains suggests the potential for use as live vectored vaccines. Full-or partial-length sequences of the gene encoding rotavirus major outer capsid protein VP7 were cloned into the open reading frame of a full-length cDNA copy of poliovirus Sabin type 3.
The poliovirus genome is composed of a positive-sense single-stranded RNA molecule that encodes a single open reading frame that is translated into a large precursor polyprotein (19) . The polyprotein is subsequently cleaved by virusencoded proteases (2A, 3C, or 3CD) to form the mature viral structural and nonstructural proteins (41, 43) . Intramolecular cleavage of the polyprotein by 2A protease releases the P1 precursor (41) , which is subsequently cleaved by 3CD to form the viral capsid proteins VPO, VP3, and VP1 (43) . Cleavage of P2 and P3 precursors by 3C protease generates the nonstructural proteins involved in the poliovirus replication process (30) . Assembly of viral capsid proteins and packaging of viral RNA result in infectious virus.
The Sabin strains of poliovirus are attenuated and, following infection of the intestinal tract, elicit strong protective immune responses without causing disease. The Sabin strains of poliovirus, therefore, are good candidates for live viral vectors to deliver foreign antigens to the enteric tract when mucosal immunity is desired for protection from disease.
The potential of chimeric polioviruses as an antigen presentation system has been studied in several laboratories for the expression of intertypic or foreign epitopes. In the former case, intertypic poliovirus chimeras have been constructed by replacing the antigenic site 1 of one poliovirus serotype with the corresponding sequence from a different serotype (4, 23, 27, 28) . Chimeric polioviruses that carry antigenic sites from other viruses on the surface-exposed loop, such as sequences of human immunodeficiency virus gp4l (9) (914) 732-5585. rus type 16 Li protein (17) , hepatitis A virus (22) , and foot-and-mouth disease virus (FMDV) (20) , have also been designed. Neutralizing antibodies to FMDV were generated in some guinea pigs immunized with poliovirus carrying FMDV epitopes. Protection following challenge with wild-type FMDV was observed in those animals that had developed neutralizing antibodies (20) . Chimeric poliovirus containing hepatitis A virus epitopes also generated antibodies, at levels that were low but similar to those reported to be protective; however, this response was seen in only a small fraction of the animals (22) . In general, success with chimeric polioviruses has been achieved with linear antigenic determinants which elicit protective immune responses as peptides alone or when conjugated to carrier macromolecules.
An alternative strategy for use of poliovirus as a vector involved replacing the region of the viral genome encoding the capsid proteins with foreign genes, generating a minireplicon. These defective viruses replicate only when cotransfected into cells with helper virus or vaccinia virus expressing the poliovirus capsid proteins (31) . In these studies, the recombinant protein is expressed as a fusion with poliovirus proteins.
The work presented here describes another approach in which a rotavirus antigen is expressed from part of the coding region of viable recombinant attenuated poliovirus. A similar experiment in which short sequences of foreign antigens were cloned in the poliovirus genome has been described previously (10) . Delivery in this manner allows both endogenous and exogenous introduction of protein or protein fragments to the immune system and greatly increases the potential for induction of universal immune reactivity in a genetically heterogeneous population with both antibodies and cell-mediated immunity being elicited. Rotaviruses are pathogens that cause dehydrating diarrhea primarily in infants (up to 2 years of age) and young animals. Antibodies generated to the two outer capsid proteins VP4 and VP7 are able to neutralize the virus. VP7 is the most abundant outer capsid protein that forms the smooth external surface of the rotavirus (7, 32, 42) and is very immunogenic in its native state as part of the viral particle.
Fourteen different rotavirus VP7 serotypes (called G serotypes) have been identified to date (24) . Human strains of rotavirus belong to four major G serotypes (G 1 to 4), but some minor strains have been identified as belonging to G serotypes 8, 9, and 12. It has been shown that local intestinal immunity is necessary for protection from rotavirus infection (for a review, see reference 5). Passive protection from rotavirus diarrhea has been achieved in mice with neutralizing monoclonal antibodies to either VP7 or VP4. VP7 has also been shown to induce cross-reactive rotavirus-specific cytotoxic T lymphocytes (14) . Although the importance of cell-mediated immunity in protection from rotavirus infections is not yet clear, cellmediated immunity may play an important role in protection from disease and for virus clearance (6) .
Several different approaches have been used to develop a rotavirus subunit vaccine, through the expression of cloned genes (full-length or partial sequences) of the outer capsid proteins VP7 and VP4, with varied results. In the case of VP7, expression in prokaryotic vectors (Escherichia coli and attenuated strains of Salmonella typhimurium) has had disappointing results, although two of the reports found that neutralizing antibodies on the order of 1/300 (26) to 1/750 (2) were generated for a bovine and a simian VP7, respectively. In most of the studies, only antibodies to denatured VP7 were induced, indicating that while an immunogenic protein was expressed, it did not assume a conformation which elicited antibodies that neutralized or bound virus (11, 18, 35) . Immunization with VP7 expressed in insect cells by recombinant baculovirus generated low levels of neutralizing antibodies in laboratory animals (8) . Immunization with baculovirus-expressed VP7 was also found to induce CD8+ T lymphocytes that mediated clearance of chronic rotavirus infection in SCID mice (6 specific activity, 46 Ci/mmol) was added. At different times p.i., the cells from duplicated wells were washed with PBS and scraped into 0.5 ml of buffer NET (50 mM Tris-HCl [pH 7.6], 100 mM NaCl, 1 mM EDTA) containing 0.5% sodium dodecyl sulfate (SDS). Trichloroacetic acid was added to the lysates to a final concentration of 20%, and the lysates were incubated on ice for 30 min. The samples were filtered onto glass microfiber filters, and radioactivity was determined by scintillation counting.
Isotopic labeling of infected cells and immunoprecipitation. Vero cells were infected with Sabin 3 or Sabin 3 recombinants at an MOI of 5. Virus adsorption was allowed for 1 h at room temperature. After the adsorption period, the inoculum was removed, fresh DMEM was added, and cells were incubated at 33.50C. At 5 h p.i., the cells were starved for I h in DMEM without methionine and cysteine. After the starving period, Tran35S-Label (ICN; specific activity, 1,028 Ci/mmol) was added to a final concentration of 80 ,uCi/ml, and the proteins were labeled for 6 to 8 h p.i. The supernatant was then removed, and the cells were lysed in radioimmunoprecipitation assay (RIPA [25] ) buffer. Labeled proteins in the infected cell lysates were separated in SDS-polyacrylamide gels either directly or after immunoprecipitation with polyclonal antisera against either poliovirus type 3, 2A protease, or rotavirus VP7.
Immunoprecipitations were carried out as previously described (25) . Briefly, the labeled cell lysates were diluted in RIPA buffer to a final volume of 300 [l and incubated on ice for 3 h with the corresponding antiserum (3 [l of anti-type 3 poliovirus, or 5 RI of anti-2A protease, or 5 RIu of anti-VP7 serum). The VP7 antiserum was prepared by immunization of a rabbit with lysates of insect cells infected with baculovirus expressing rotavirus VP7. Protein G-Sepharose was added, and the beads were incubated with the immune complexes for 2 h. The beads were then washed three times with RIPA buffer as previously described (25) (Fig. 2) .
RT-PCR was used to confirm the presence of inserted VP7 fragments in viruses recovered from transfections of Vero cells with recombinant pLED3/VP7 transcripts. In the RT-PCR assay, the poliovirus region spanning the site of gene insertion was amplified. The PCR product is 250 or 185 bp plus the size of the insert for virus derived from pVl and pV2, respectively. In some cases, primers corresponding to the 5' and 3' ends of the cloned VP7 region were used for confirmation of the VP7 gene (not shown). Several of the recovered viruses were found to be positive by RT-PCR for the presence of inserted VP7 fragments of the correct size (as illustrated in Fig. 3A , lanes 2 and 3, for V1/150 and V1/178, respectively). Other recombinant viruses were found to be negative for the VP7 sequences, or the RT-PCRs showed a band that was only slightly larger than that corresponding to the negative control (Fig. 3A, 298 ) of VP7 in frame with the poliovirus polyprotein. The sequence of the PCR product from virus derived from another plaque-purified virus (V2/A178c14) also showed a deletion in the middle of the insert of 390 bases. In this case, 144 bases were left, coding for 48 aa of VP7 (aa 150 to 182 plus aa 312 to 326). One interesting virus is V1/A101c4, in which the deletion started at the Sabin 3 nucleotide 722 in the noncoding region and continued into the NotI site and the VP7 insert. In this case, the translation of the polyprotein possibly starts at the AUG codon for methionine 310 of the VP7 sequence. In other cases, the deletions are just at the 5' end (not shown) or at the 3' end of the VP7 inserts (V2/A150c7 and V2/A101c9).
All deletions resulted in the open reading frame being maintained, which was expected in order to obtain viable viruses. Deletions in the inserted sequences might stabilize the recombinant Sabin 3 viruses, and these populations might be subsequently selected in cell culture. The deletions seemed to be at random. So far, we were not able to find results indicative of specific mechanisms of deletion or specific sequences at which the deletions were produced. The only common feature was the selection of an insert size under 300 bp.
Expression of rotavirus VP7 in cells infected with recombinant polioviruses. Infectious recombinant viruses were studied to determine whether the truncated VP7 proteins were expressed and correctly processed from the polyprotein in cells infected with recombinant Sabin 3 polioviruses.
Vero cells were infected with transfection supernatants and metabolically labeled with Tran35S-Label for 2 h (from 6 to 8 h p.i.). The labeled proteins were immunoprecipitated with antiserum against rotavirus VP7 and analyzed by SDS-polyacrylamide gel electrophoresis and autoradiography (Fig. 4) . 1 2 3 4 5 6 7 8 9 10 respectively. Apparently, the recombinants are not as efficient as Sabin 3 in the shutdown of host protein synthesis. Lanes 6 to 10 of Fig. 4 show labeled lysates immunoprecipitated with anti-VP7 antiserum. Several high-molecular-weight uncleaved precursors are seen, as well as polypeptides running in the region of the gel corresponding to the expected molecular weights of the VP7 inserts (lanes 7 and 8). These polypeptides are not seen in Sabin 3-infected labeled lysates (lane 6).
The kinetics of RNA synthesis are similar, but virus assembly is slower for the Sabin 3/VP7 recombinants. The rate of viral RNA synthesis was measured for Sabin 3 (40) .
Despite the similar RNA kinetics, one-step growth curves of viral production showed that infectious Sabin 3 viruses were assembled more rapidly than the Sabin 3/VP7 recombinants, which presented an average of a 2-h delay (Fig. 5B) . Virion assembly of Sabin 3 started at about 6 h p.i., whereas that of the recombinants started at about 8 h p.i. The fact that the cycles were slower for the recombinants is also demonstrated by the final titers obtained after overnight incubation of infected cells. The titers of Sabin 3 after 20 h of incubation remained the same as the titers at 12 h p.i., while the final titers at 20 h p.i. were three-and twofold higher than at 12 h p.i. for V1/101 and V2/101, respectively (Fig. 5B) (B) One-step growth curves. Vero cells were infected as described above with the same viruses. After adsorption, the inoculum was washed, fresh medium was added, and infections were stopped at different times p.i. The cells plus the supernatants were freeze-thawed three times before titration on Vero cell monolayers. Virus titers are expressed as PFU per milliliter on a logarithmic scale. 0, Sabin 3; *, V1/101; Ol, V2/101. V2/101 was 1 and 1.5 logs lower, respectively, compared with Sabin 3, despite the longer growth cycles of the former two viruses. Both recombinants also showed smaller-size plaques than Sabin 3.
Inefficient cleavage of the VP7 protein may be a determinant of stability of Sabin 3/VP7 recombinants. The expression of VP7-containing precursors was examined in cells infected with the viruses containing stable VP7 inserts V1/101 and V2/101. In this experiment, the accumulation of precursors observed was dependent on the type of fusion generated and the antiserum used (either anti-polio, anti-VP7, or anti-2A).
V1/101, which contains 303 bp of VP7 (12.4K) cloned at the 5' end of the poliovirus polyprotein, showed accumulation of a 50K precursor (Fig. 6A, lane 1) (Fig. 6A, lane 1) .
In Fig. 6B 
DISCUSSION
The use of an attenuated strain of poliovirus for expression of a foreign antigen was investigated in this work. Incorporation of up to 534 bp of the rotavirus VP7 gene in the genome of Sabin 3 poliovirus gave rise to infectious viruses that expressed portions of rotavirus VP7 in infected cells. However, only viruses carrying inserts of about 300 bp or smaller were able to maintain the foreign sequences in their genomes without further deletions upon passage in tissue culture. These initial results are encouraging and indicate the possibility of using Sabin strains as live vectors, although more work is needed to improve the system, specifically with regard to the size and the nature of the foreign sequences to be inserted.
Recombinant clones containing larger VP7 inserts failed to produce infectious viruses. There are several reasons why this may occur: (i) a deleterious effect on RNA replication or translation, (ii) failure of proper protease cleavage due to conformational constraints, (iii) spatial relationship between artificial protease sites and the protease if the cleavage is made in cis, (iv) influence of the nature of the foreign sequences on the efficiency of protease cleavage, and (v) the presence of the VP7 signal peptide in some of the constructs. Work done with other viral antigens in our laboratory (not shown) strongly supports the idea that the success of the system is dependent on the nature of the sequences inserted.
A comparison of the Sabin 3/VP7 recombinants with their Sabin 3 parent showed no significant differences regarding the kinetics of viral RNA synthesis in infected cells, but the recombinants were found to be slower in the assembly of infectious virus. The recombinant viruses showed smaller plaques, and titers were usually 1 to 1.5 logs lower than Sabin 3.
One of our working hypotheses is that slow assembly of the and its natural cleavage site. The 2A-mediated cleavage at the VP1-VP7 junction appears to be unaffected, as demonstrated by the ability to recover viable viruses. However, we were not able to detect free VP7 when the fragments are cloned at the junction of P1 and P2 (pV2 vectors).
It was observed that for duplicate short inserts engineered separately in pVl and pV2, those in pV2 resulted in infectious viruses more readily. We have demonstrated that 2A-mediated cleavage occurs in the presence of intervening sequences; however, we speculate that viruses that did not process the VP7 insert from the 2A protease through the artificial 3C protease site (or processed it very slowly) would still be viable. In this case, either very small amounts of 2A may be necessary for the viral replication or the functions of 2A can still be carried out by a 2A-VP7 fusion protein. Even when free VP7 was not detected in V2 viruses, free 2A was detected with anti-2A antiserum. The size of the insert between the 2A protease sequences and the 2A cleavage site may also influence the efficiency of the cleavage.
These results suggest that if the efficiency of cleavage at the artificial sites can be increased, the viability of the poliovirus recombinants might also improve. It is also possible that larger-size inserts may be accommodated, especially at the 5' end of the polyprotein. This may be dependent on the nature of the sequences inserted and on the secondary and tertiary structure that they adopt in the polyprotein.
Our viable Sabin 3/VP7 constructs include the carboxylterminal region of VP7. Current work includes the construction of recombinant Sabin 3 viruses carrying shorter aminoterminal fragments of VP7 with and without the signal peptide. Although the generation of viable viruses may correlate with the nonfunctionality of the VP7 signal peptide, the feasibility of such constructs is of interest because the only cytotoxic T-lymphocyte epitope found in VP7 overlaps the second signal sequence (12) . While the amino-terminal regions of VP7 are highly variable and have conformation-dependent serotypespecific epitopes, the carboxy-terminal region has been found to be structurally conserved in the three antigenic rotavirus groups, A, B, and C (aa 192 to 231 and aa 278 to 309) (24) . Moreover, portions of this region may be exposed, as suggested by computer analysis and by the finding of a neutralization escape mutant with a mutation at aa 291 (21) . In another report, a peptide made to aa 275 to 295 and a monoclonal antibody to this peptide blocked virus adsorption to cells in culture (13, 34) . However, as described in the Introduction, other attempts at using recombinant VP7 as a vaccine were not very successful (for reviews, see references 5, 7, and 24). Another potential antigen of interest is the outer capsid protein VP4. Promising results have been obtained with VP4 peptides and recombinant VP4 expressed in different systems (16, 24) . We are presently cloning selected regions of rotavirus VP4 in newly designed vectors.
There are several advantages to using Sabin strains of poliovirus as vaccine vectors for the development of multivalent vaccines combined with oral polio vaccine. Work in progress in our laboratory includes cloning of other antigens in both Sabin 3 and Sabin 1 backgrounds and immunogenicity studies in transgenic mice that express the human poliovirus receptor (33) . Conclusions based on rotavirus VP7 may not hold true for all other antigens to be expressed in Sabin vectors, but the accumulated understanding of this system will be very useful for future applications with other viral or bacterial antigens for which mucosal immunity is critical for protection from disease.
